Emergency Use
-
{
- All
- News
- Videos
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
Recommendations On Covaxin Emergency Use For 2-18 Age Group Being Examined: Centre
The Covid Subject Expert Committee's recommendations on granting emergency use authorisation to Bharat Biotech's Covaxin for the 2-18 age group are being examined and additional information has been sought, Rajya Sabha was informed Tuesday.
-
What Covaxin-Maker Bharat Biotech Said After WHO Approved India-Made Jab
The World Health organisation's approval of Covaxin will expedite global access and availability of the first India-made vaccine against coronavirus worldwide, its manufacturer Bharat Biotech said in a statement.
-
"Takes Longer Sometimes": Top WHO Official As Covaxin Decision Awaited
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.
-
Decision On Covaxin Clearance Next Week, Says WHO
Covaxin, India's indigenously developed coronavirus vaccine, may be cleared by the World Health Organisation as early as next week when the UN agency and an independent group of experts meet.
-
WHO's Emergency Use Authorization For Covaxin "Expected Soon": Health Ministry
The Health Ministry on Friday hinted that the World Health Organization's (WHO) Emergency Use Authorization (EUA) for the COVID-19 vaccine, Covaxin, is expected soon.
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
-
Inching Toward Emergency Use Listing By WHO For Covaxin: Bharat Biotech
Emergency Use Listing of Bharat Biotech's Covaxin by WHO is not a long drawn process as a majority of the vaccine makers' facilities have been audited by the global health body, Suchitra Ella, joint managing director of Bharat Biotech, said today.
-
Explained: For Covaxin's Global Emergency Listing, Key Meet With WHO
Bharat Biotech and the World Health Organization held a 'pre-submission' meeting on Wednesday for international emergency use listing (EUL) of Covaxin, the Hyderabad-based company's COVID-19 vaccine
-
Pfizer Covid Vaccine Not Recommended For Emergency Use 'At This Stage': Expert Panel
Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage, officials told news agency Press Trust of India on Friday.
-
Brazil Authorises Emergency Use Of 2 Vaccines As Covid Enters Second Wave
Brazilian health regulator Anvisa on Sunday approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca, clearing the way for immunizations as the pandemic enters a deadly second wave.
-
Pfizer Must Conduct Local Study For Vaccine Approval: Official
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Covid Vaccine Roll-Out By Next Week? What Government Said
The Covid-19 vaccine can be rolled out within 10 days from the emergency use authorisation date, based on dry run feedback, the government said today, ending speculation about the time frame that started since the drug regulator's announcement on Sunday.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
-
India's Corbevax Vaccine Gets WHO Emergency Use Listing Authorisation
India's COVID-19 vaccine, Corbevax, has been granted an Emergency Use Listing by the World Health Organisation, the company which manufactures it in India said Hyderabad today.
-
Recommendations On Covaxin Emergency Use For 2-18 Age Group Being Examined: Centre
The Covid Subject Expert Committee's recommendations on granting emergency use authorisation to Bharat Biotech's Covaxin for the 2-18 age group are being examined and additional information has been sought, Rajya Sabha was informed Tuesday.
-
What Covaxin-Maker Bharat Biotech Said After WHO Approved India-Made Jab
The World Health organisation's approval of Covaxin will expedite global access and availability of the first India-made vaccine against coronavirus worldwide, its manufacturer Bharat Biotech said in a statement.
-
"Takes Longer Sometimes": Top WHO Official As Covaxin Decision Awaited
As a decision is awaited on the Emergency Use Listing of Covaxin being manufactured in India, a top WHO official has said the process of thoroughly evaluating a vaccine for use and recommending it sometimes takes a longer time.
-
Decision On Covaxin Clearance Next Week, Says WHO
Covaxin, India's indigenously developed coronavirus vaccine, may be cleared by the World Health Organisation as early as next week when the UN agency and an independent group of experts meet.
-
WHO's Emergency Use Authorization For Covaxin "Expected Soon": Health Ministry
The Health Ministry on Friday hinted that the World Health Organization's (WHO) Emergency Use Authorization (EUA) for the COVID-19 vaccine, Covaxin, is expected soon.
-
Bharat Biotech Dossier Under Review For Covaxin Emergency Use Listing: WHO
Officials of the World Health Organisation (WHO) had a meeting with the Bharat Biotech and its dossier for Emergency Use Listing of Covaxin is under review by technical experts, Dr Poonam Khetrapal Singh, Regional Director, WHO South-East Asia said.
-
Inching Toward Emergency Use Listing By WHO For Covaxin: Bharat Biotech
Emergency Use Listing of Bharat Biotech's Covaxin by WHO is not a long drawn process as a majority of the vaccine makers' facilities have been audited by the global health body, Suchitra Ella, joint managing director of Bharat Biotech, said today.
-
Explained: For Covaxin's Global Emergency Listing, Key Meet With WHO
Bharat Biotech and the World Health Organization held a 'pre-submission' meeting on Wednesday for international emergency use listing (EUL) of Covaxin, the Hyderabad-based company's COVID-19 vaccine
-
Pfizer Covid Vaccine Not Recommended For Emergency Use 'At This Stage': Expert Panel
Just two days before pharma major Pfizer announced withdrawal of its application for emergency use authorisation of its COVID-19 vaccine in India, an expert panel of the country's drugs regulatory authority had recommended against granting such approval to the firm at this stage, officials told news agency Press Trust of India on Friday.
-
Brazil Authorises Emergency Use Of 2 Vaccines As Covid Enters Second Wave
Brazilian health regulator Anvisa on Sunday approved emergency use of COVID-19 vaccines from China's Sinovac Biotech Ltd and Britain's AstraZeneca, clearing the way for immunizations as the pandemic enters a deadly second wave.
-
Pfizer Must Conduct Local Study For Vaccine Approval: Official
Any vaccine maker, including Pfizer Inc, which has sought emergency-use authorisation for its COVID-19 shot in India, must conduct a local "bridging" safety and immunogenicity study to be considered for the country's immunisation programme, a senior government official told Reuters.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Covid Vaccine Roll-Out By Next Week? What Government Said
The Covid-19 vaccine can be rolled out within 10 days from the emergency use authorisation date, based on dry run feedback, the government said today, ending speculation about the time frame that started since the drug regulator's announcement on Sunday.
-
US Drug Regulator Recommends Emergency Approval Of Moderna Vaccine
The US Food and Drug Administration (FDA) will "rapidly" work towards granting emergency approval of Moderna Inc's COVID-19 vaccine candidate, FDA Commissioner Stephen Hahn said on Thursday.
